A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma
- 1 June 2007
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 852 (1-2), 436-442
- https://doi.org/10.1016/j.jchromb.2007.02.014
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Sensitive liquid chromatography-tandem mass spectrometry method for quantification of hydrochlorothiazide in human plasmaBiomedical Chromatography, 2005
- Determination of hydrochlorothiazide and irbesartan in pharmaceuticals by fourth-order UV derivative spectrophotometryIl Farmaco, 2005
- Antihypertensive Efficacy and Tolerability of Two Fixed-Dose Combinations of Valsartan and Hydrochlorothiazide Compared with Valsartan Monotherapy in Patients with Stage 2 or 3 Systolic Hypertension: An 8-Week, Randomized, Double-Blind, Parallel-Group TrialClinical Therapeutics, 2005
- Development of solid-phase extraction method and its application for determination of hydrochlorothiazide in human plasma using HPLCBiomedical Chromatography, 2004
- Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresisJournal of Pharmaceutical and Biomedical Analysis, 2003
- Simultaneous determination of irbesartan and hydrochlorothiazide in human plasma by liquid chromatographyJournal of Chromatography B, 2002
- Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulationJournal of Pharmaceutical and Biomedical Analysis, 2002
- Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first-derivative ultraviolet spectrophotometry and LCJournal of Pharmaceutical and Biomedical Analysis, 2001
- Valsartan: a novel angiotensin Type 1 receptor antagonistExpert Opinion on Pharmacotherapy, 2000
- ValsartanDrugs, 1997